文献速递牙周病牙体牙髓病

牙周治疗与降低糖尿病相关医疗费用相关:牙科与医疗理赔数据分析

Periodontal treatment associated with decreased diabetes mellitus-related treatment costs: An analysis of dental and medical claims data.
PubMed 文献 · J Am Dent Assoc · 2023-02-24

该研究基于IBM MarketScan商业保险与医疗补助理赔数据,分析2017至2018年牙周服务使用与2019年糖尿病患者人均医疗费用的关联。商业保险组牙周治疗与总费用降低12%相关,医疗补助组降低14%,住院费用(商业保险)或药品费用(医疗补助)无显著差异。作者认为健康口腔在糖尿病管理中可能起关键作用,扩大医疗补助覆盖全面牙周治疗有降低医疗费用的潜力。

要点

  • 商业保险糖尿病患者中,牙周治疗与总医疗费用降低12%相关($13,915 vs $15,739)。
  • 医疗补助糖尿病患者中,牙周治疗与总医疗费用降低14%相关($14,796 vs $17,181)。
  • 住院费用(商业保险)或药品费用(医疗补助)无显著差异。

核心结论

  • 接受牙周治疗与医疗补助和商业保险理赔数据中糖尿病患者总体及门诊医疗费用降低相关。
  • 商业保险参保者住院费用或医疗补助受益人药品费用无显著差异。

研究设计与样本

  • 基于IBM MarketScan商业保险和医疗补助数据库的分析,纳入糖尿病患者总体门诊、住院和药品费用。
  • 使用广义线性模型分析2017至2018年牙周服务使用与2019年每患者总体医疗费用的关联。
  • 通过倾向性评分匹配计算处理组的平均处理效应,协变量包括牙周治疗logistic模型。

主要发现

  • 商业保险参保者中,牙周治疗与总医疗费用降低12%相关($13,915 vs $15,739;平均处理效应,-$2,498.20;95%CI,-$3,057.21至-$1,939.19;P<.001)。
  • 医疗补助队列中,牙周治疗与费用降低14%相关($14,796 vs $17,181;平均处理效应,-$2,917.84;95%CI,-$3,354.48至-$2,480.76;P<.001)。
  • 商业保险住院费用或医疗补助药品费用无显著差异。

临床怎么用

  • 作者认为健康口腔在糖尿病管理中可能起关键作用。
  • 作者认为扩大医疗补助福利以涵盖全面牙周治疗有降低糖尿病患者医疗费用的潜力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes mellitus (DM) and periodontal disease have a suggested bidirectional relationship. Researchers have reported decreases in DM-related health care costs after periodontal treatment. The authors examined the relationship between periodontal disease treatment and DM health care costs in commercial insurance and Medicaid claims data. METHODS: This study of IBM MarketScan commercial insurance and Medicaid databases included overall outpatient, inpatient, and drug costs for patients with DM. The authors examined associations between overall health care costs per patient in 2019 according to use of periodontal services from 2017 through 2018 using generalized linear modeling. The average treatment effect on treated was calculated by means of propensity score matching using a logistic model for periodontal treatment on covariates. RESULTS: For commercial insurance enrollees, periodontal treatment was associated with reduced overall health care costs of 12% compared with no treatment ($13,915 vs $15,739; average treatment effect on treated, -$2,498.20; 95% CI, -$3,057.21 to -$1,939.19; P < .001). In the Medicaid cohort, periodontal treatment was associated with a 14% decrease in costs compared with patients with DM without treatment ($14,796 vs $17,181; average treatment effect on treated, -$2,917.84; 95% CI, -$3,354.48 to -$2,480.76; P < .001). There were no significant differences in inpatient costs (commercial insurance) or drug costs (Medicaid). CONCLUSIONS: Undergoing periodontal treatment is associated with reduced overall and outpatient health care costs for patients with DM in Medicaid and commercial insurance claims data. There were no significant differences in inpatient costs for commercial insurance enrollees or in drug costs for Medicaid beneficiaries. PRACTICAL IMPLICATIONS: A healthy mouth can play a key role in DM management. Expanding Medicaid benefits to include comprehensive periodontal treatment has the potential to reduce health care costs for patients with DM.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Thakkar-Samtani M, Heaton LJ, Kelly AL, et al. Periodontal treatment associated with decreased diabetes mellitus-related treatment costs: An analysis of dental and medical claims data. J Am Dent Assoc. 2023. PMID: 36841690. doi:10.1016/j.adaj.2022.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。